#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Idiopathic inflammatory myopathy Fontan procedure Sickle cell disease Waldenstrom's macroglobulinaemia Chondrodystrophy Neurodegenerative disorder Usher's syndrome Polycythaemia vera Familial amyotrophic lateral sclerosis Breast cancer Philadelphia positive acute lymphocytic leukaemia Small cell lung cancer recurrent Neuroendocrine carcinoma of the skin Parkinson's disease Colon cancer More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome – Diagnostics Rosai-Dorfman syndrome – Treatment Factor VIII deficiency – Diagnostics Loeys-Dietz syndrome – Trials in Disease Hereditary hypophosphataemic rickets – Treatment Proteus syndrome – Diagnostics Kearns-Sayre syndrome – Treatment Netherton’s syndrome – Basic Information Alport’s syndrome – Diagnostics Brain stem glioma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Empagliflozin Aminocaproic Acid Gallium (68Ga) Gozetotide F125/10 Tafasitamab Flupentixol Decanoate Ht-29-A STREPTOCOCCUS VIRIDANS Efepoetin Alfa Placebo Liraglutide Naloxegol Oxalate Mk-0616 Kk8123 Melphalan Flufenamide Calcium Chloride Vonicog Alfa GSKVX000000070248 4-IODOPHENYLALANINE I-131 Palonosetron More therapies…

    Learn about Your Condition

    Tourette's disorder Coma Vulvar dysplasia Kawasaki's disease Muscle hypertrophy Dry eye Macular oedema Acarodermatitis Yellow fever Insomnia Acute respiratory failure Skin ulcer Kidney transplant rejection Osteochondrodysplasia Post-traumatic headache More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Glioblastoma

  • Study of iodofalan (131I) and lomustine combination therapy compared to lomustine alone in patients with first recurrent glioblastoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • 4-IODOPHENYLALANINE I-131
    • Lomustine
    Austria Belgium Denmark France Germany The Netherlands +1

  • Study on the Effectiveness of Optune with Temozolomide and Pembrolizumab in Patients with Newly Diagnosed Glioblastoma

    Recruiting

    3 1 1
    Investigated Drugs:
    • Temozolomide
    • Pembrolizumab
    Czechia France Germany Italy Poland Spain

  • Study on Adding Zoledronic Acid to Standard Treatment for Patients with Glioblastoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Zoledronic Acid Monohydrate
    Latvia

  • Study of Itraconazole with Radiotherapy and Temozolomide for Patients with Newly Diagnosed Glioblastoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Itraconazole
    Germany

  • Study on the Use of Metformin in Addition to Standard Treatment for Patients with Glioblastoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Metformin Embonate
    Italy

  • Study on A49, A52, and Litenimod Sodium for Patients with Glioblastoma

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • A49
    • A52
    • Litenimod Sodium
    France
1 2 3 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!